레이저옵텍

199550KOSDAQ의료용 기기 제조업

39.8 / 100

Reference Date: 2026-04-13

Financial Score7.0 / 40

News Sentiment13.8 / 25

Momentum4.0 / 20

Disclosure15.0 / 15

AI Analysis: ROE is below the industry average, Revenue is on a declining trend. Slightly down 3.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Laser Optec, established in 2000, initially focused on laser products for semiconductor and automotive manufacturing. It entered the laser beauty device market in 2005 and obtained FDA and CE certifications for international expansion. In 2016, the company launched the world's first PALLAS device using Ti:Sapphire technology for vitiligo treatment, and plans to expand its medical device portfolio for conditions like vascular lesions and kidney stones, while diversifying into ultrasound and other energy sources.

Number of Employees

93people

Average Salary

48.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 26.524.0Point

PBR

2.80Industry Average 1.701.0Point

1.6x industry avg (risky)

ROE

-40.82Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

13.58Industry Average 10.952.0Point

Higher than industry avg (caution)

Trend 2023~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼13.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼3074.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -14.6% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 1Neutral 0Negative 0Average Sentiment Score 70

Positive
레이저옵텍, 키메스서 ‘바스큐라589’ 공개...혈관 레이저의 새 지평...
레이저옵텍은 키메스에서 세계 최초 고출력 589nm 고체 혈관 레이저인 ‘바스큐라589’를 공개하고 아가파클리닉네트워크와 선계약을 체결했습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 5,070Won52-week high 9,87152-week low 4,560

1-month return2.0Point

1m -3.61% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

17 totalPositive 3Neutral 14Negative 0

Positive유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모)2026-04-10
Positive[기재정정]주요사항보고서(유상증자결정)2026-04-06
Neutral[발행조건확정]증권신고서(지분증권)2026-04-06
Positive유상증자최종발행가액확정 (주주배정후 실권주 일반공모)2026-04-06
Neutral[기재정정]투자설명서2026-04-06